Phytotherapy

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Running total of the number of research papers listed on PubMed from 1990-2007 containing the word "phytotherapy."[original research?]

Phytotherapy is the study of the use of extracts of natural origin as medicines or health-promoting agents. Phytotherapy medicines differ from plant-derived medicines in standard pharmacology. Where standard pharmacology isolates an active compound from a given plant, phytotherapy aims to preserve the complexity of substances from a given plant with relatively less processing.

Phytotherapy is distinct from homeopathy and anthroposophic medicine, and avoids mixing plant and synthetic bioactive substances. Traditional phytotherapy is a synonym for herbalism and regarded as alternative medicine by much of Western medicine. Although the medicinal and biological effects of many plant constituents such as alkaloids (morphine, atropine etc.) have been proven through clinical studies, there is debate about the efficacy and the place of phytotherapy in medical therapies.

Modern phytotherapy, following the scientific method, can be considered the study on the effects and clinical use of herbal medicines.

Clinical tests[edit]

The bark of the cinchona tree contains quinine, which today is a widely prescribed treatment for malaria, especially in countries that cannot afford to purchase the more expensive anti-malarial drugs produced by the pharmaceutical industry.

Many herbs have shown positive results in-vitro, animal model or small-scale clinical tests,[1] while studies on some herbal treatments have found negative results.[2]

In 2002, the U.S. National Center for Complementary and Alternative Medicine of the National Institutes of Health began funding clinical trials into the effectiveness of herbal medicine.[3] In a 2010 survey of 1000 plants, 356 had clinical trials published evaluating their "pharmacological activities and therapeutic applications" while 12% of the plants, although available in the Western market, had "no substantial studies" of their properties.[4]

Even widely used remedies may not have undergone substantial clinical testing. In a review on herbal medicine in Malaria treatment, the authors found that "...better evidence from randomised clinical trials is needed before herbal remedies can be recommended on a large scale. As such trials are expensive and time consuming, it is important to prioritise remedies for clinical investigation...."[5]

Points to consider in phytotherapy[edit]

Standardization[edit]

In herbal medicine, plant material that has been processed in a repeatable operation so that a discrete marker constituent is at a verified concentration is then considered standardized. Active constituent concentrations may be misleading measures of potency if cofactors are not present. A further problem is that the important constituent is often unknown. For instance St John's wort is often standardized to the antiviral constituent hypericin which is now known to be the active ingredient for antidepressant use. Other companies standardize to hyperforin or both, although there may be some 24 known possible constituents. Only a minority of chemicals used as standardization markers are known to be active constituents. Standardization has not been standardized yet: different companies use different markers, or different levels of the same markers, or different methods of testing for marker compounds. Herbalist and manufacturer David Winston points out that whenever different compounds are chosen as 'active ingredients' for different herbs, there is a chance that suppliers will get a substandard batch (low on the chemical markers) and mix it with a batch higher in the desired marker to compensate for the difference.[6]

Quality[edit]

The quality of crude drugs or plant medicines depends upon a variety of factors, including the variability in the specie (or species) of plant being used; the plant's growing conditions (i.e. soil, sun, climate); and the timing of harvest, post-harvest processing, and storage conditions. The quality of some plant drugs can judged by Organoleptic factors (i.e. sensory properties such as the taste, color, odor or feel of the drug), or by administering a small dose of the drug and observing the effects. These conditions have been noted in historical herbals such as Culpepper's Complete Herbal[7] or The Shen Nong or Divine Farmer's Materia Medica.[8]

Modern Phytotherapy may use traditional methods of assessment of herbal drug quality, but more typically relies on modern processes like HPLC (High performance liquid chromatography), GC (gas chromatography), UV/VIS (Ultraviolet/Visible spectrophotometry) or AA (atomic absorption spectroscopy). These are used to identify species, measure bacteriological contamination, assess potency and eventually create Certificates of Analysis for the material.[citation needed]

Quality should be overseen by either authorities ensuring Good Manufacturing Practices or regulatory agencies by the US FDA. In the United States one frequently sees comments that herbal medicine is unregulated, but this is not correct since the FDA and GMP regulations are in place. In Germany, the Commission E has produced a book of German legal-medical regulations which includes quality standards.[9]

Safety[edit]

A number of herbs are thought to be likely to cause adverse effects.[10] Such herbs, like most herbs for example in Traditional Chinese Medicine, are used in small doses within the herbal formula. Common sense is essential when working with, and consuming, plant-based medicinal products.

Furthermore, "adulteration, inappropriate formulation, or lack of understanding of plant and drug interactions have led to adverse reactions that are sometimes life threatening or lethal."[11] Proper double-blind clinical trials are needed to determine the safety and efficacy of each plant before they can be recommended for medical use.[12] Although many consumers believe that herbal medicines are safe because they are "natural", herbal medicines may interact with synthetic drugs causing toxicity to the patient, may have contamination that is a safety consideration, and herbal medicines, without proven efficacy, may be used to replace medicines that have a proven efficacy.[13]

The political issues around the safety of crude drugs vary from considering natural remedies "safe" regardless of potential dangers to considering them a dangerous unknown.[14]

Ephedra has been known to have numerous side effects, including severe skin reactions, irritability, nervousness, dizziness, trembling, headache, insomnia, profuse perspiration, dehydration, itchy scalp and skin, vomiting, hyperthermia, irregular heartbeat, seizures, heart attack, stroke, or death.[15] Ephedra has been an object of difficulty; having legitimate western medicine uses, illegal uses and powerful side effects. Known and used as Mormon Tea or Indian Tea, the plant contains the potent chemical drugs ephedrine and pseudoephedrine. Aside from being chemicals used to create methamphetamine they have direct central nervous system (CNS) stimulant effects including high blood pressure and high heart rate. These effects have led to strokes and other CNS or cardiac issues in certain people at certain dosages. In recent years, the safety of ephedra-containing dietary supplements has been questioned by the United States Food and Drug Administration (FDA), the National Center for Complementary and Alternative Medicine, and the medical community as a result of reports of serious side effects and ephedra-related deaths.[16][17][18][19][20] However, when used appropriately by the correct people it is an effective decongestant, a bronchodilator for use in asthma and an adjuvant for the common cold.

Other plants contain potent alkaloids which may cause physical harm when used incorrectly, but are not treated as possibly dangerous, leaving an uninformed public at risk for side effects or herb to chemical drug interactions. Gingko biloba arguably has positive effects for many people but it is a blood thinner which may increase or cause spontaneous bleeding. White Willow, the source of salicin which through salicylic acid is the base for acetylsalicylic acid or Aspirin. Salicylate drugs such as A.S.A. are effective in reducing pain and fever but are also blood thinners. If, for example, one were to take Gingko Biloba and White Willow reduced blood clotting may lead to increased length of wound bleeding or to situations such as hematuria.

Plants such as Comfrey[21][22] and Petasites have specific toxicity due to hepatotoxic pyrrolizidine alkaloid content.[23][24] There are other plant medicines which require caution or can interact with other medications, including St. John's wort and grapefruit.[25]

"Paraherbalism"[edit]

Phytochemical researcher Varro Eugene Tyler described paraherbalism as "faulty or inferior herbalism based on pseudoscience", using scientific terminology but lacking scientific evidence for safety and efficacy. Tyler listed ten fallacies that distinguished herbalism from paraherbalism, including claims that there is a conspiracy to suppress safe and effective herbs, herbs can not cause harm, that whole herbs are more effective than molecules isolated from the plants, herbs are superior to drugs, the doctrine of signatures (the belief that the shape of the plant indicates its function) is valid, dilution of substances increases their potency (a doctrine of the pseudoscience of homeopathy), astrological alignments are significant, animal testing is not appropriate to indicate human effects, anecdotal evidence is an effective means of proving a substance works and herbs were created by God to cure disease. Tyler believes that none of these beliefs have any basis in fact.[26][27]

Criticism[edit]

Some herbalists criticize the manner in which many scientific studies make insufficient use of historical knowledge, which has been shown useful in drug discovery and development in the past and present.[28] They maintain that this traditional knowledge can guide the selection of factors such as optimal dose, species, time of harvesting and target population.[29]

Regulation[edit]

In 1994, the US Congress passed the Dietary Supplement Health and Education Act (DSHEA), regulating labeling and sales of herbs and other supplements. Most of the 2000 U.S. companies making herbal or natural products[30] choose to market their products as food supplements that did not require substantial testing and gave no assurance of safety and efficacy. With the implementation of the Current Good Manufacturing Practices (CGMPs) for Dietary Supplements in 2007, the situation improved. Since then all US companies importing, manufacturing or selling these products must comply with Federal Register Volume 72, Number 121, to test for identity, purity and strength of all dietary supplements including herbal products, and investigate quality deviations through a Corrective and preventive action (CAPA) plan. Furthermore the United States Pharmacopeia has incorporated more quality control monographs for herbs and supplements, which are officially accepted testing protocols by the Food and Drug Administration. New dietary supplement ingredients that were previously not marketed in the US require a product approval process.

Limitations[edit]

Some diseases have no known effective herbal treatment. One large category of such disease is cancer. According to Cancer Research UK, "there is currently no strong evidence from studies in people that herbal remedies can treat, prevent or cure cancer".[31]

See also[edit]

References[edit]

  1. ^ Srinivasan K (2005). "Spices as influencers of body metabolism: an overview of three decades of research". Food Research International 38 (1): 77–86. doi:10.1016/j.foodres.2004.09.001. 
  2. ^ Pittler, M; Abbot, NC; Harkness, EF; Ernst, E (2000). "Location bias in controlled clinical trials of complementary/alternative therapies". International Journal of Epidemiology 53 (5): 485–489. doi:10.1016/S0895-4356(99)00220-6. PMID 10812320. 
  3. ^ Herbal Medicine, NIH Institute and Center Resources, National Center for Complementary and Alternative Medicine, National Institutes of Health.
  4. ^ Cravotto G, Boffa L, Genzini L, Garella D (February 2010). "Phytotherapeutics: an evaluation of the potential of 1000 plants". J Clin Pharm Ther 35 (1): 11–48. doi:10.1111/j.1365-2710.2009.01096.x. PMID 20175810. 
  5. ^ "Traditional herbal medicines for malaria" (BMJ 2004; 329 doi: http://dx.doi.org/10.1136/bmj.329.7475.1156 (Published 11 November 2004))
  6. ^ Alan Tillotson Growth, Maturity, Quality
  7. ^ Culpeper's Complete Herbal by Nicholas Culpeper reprinted in 2003 by Kensington Arts Press
  8. ^ The Divine Farmer's Materia Medica: A Translation of the Shen Nong Ben Cao (Blue Poppy's Great Masters Series) by Yang Shou-Zhong and Bob Flaws (translator) Blue Poppy 1998
  9. ^ Making Sense of Commission E, review by Jonathan Treasure, 1999-2000.
  10. ^ Talalay P. and Talalay P., "The Importance of Using Scientific Principles in the Development of Medicinal Agents from Plants", Academic Medicine, 2001, 76, 3, p238.
  11. ^ Elvin-Lewis, M. (2001). "Should we be concerned about herbal remedies". Journal of Ethnopharmacology 75 (2-3): 141–164. doi:10.1016/S0378-8741(00)00394-9. PMID 11297844. 
  12. ^ Vickers AJ (2007). "Which botanicals or other unconventional anticancer agents should we take to clinical trial?". J Soc Integr Oncol 5 (3): 125–9. doi:10.2310/7200.2007.011. PMC 2590766. PMID 17761132. 
  13. ^ Ernst E (2007). "Herbal medicines: balancing benefits and risks". Novartis Found. Symp. 282: 154–67; discussion 167–72, 212–8. doi:10.1002/9780470319444.ch11. PMID 17913230. 
  14. ^ [Jane Brody. Taking Stock of Mysteries of Medicine]http://query.nytimes.com/gst/fullpage.html?res=9A05EEDC1F3EF936A35756C0A96E958260&sec=health&spon=&pagewanted=2
  15. ^ Ephedra information from Memorial Sloan-Kettering Cancer Center. Accessed April 11, 2007.
  16. ^ Haller C, Benowitz N (2000). "Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids". N Engl J Med 343 (25): 1833–8. doi:10.1056/NEJM200012213432502. PMID 11117974. 
  17. ^ Bent S, Tiedt T, Odden M, Shlipak M (2003). "The relative safety of ephedra compared with other herbal products". Ann Intern Med 138 (6): 468–71. PMID 12639079. 
  18. ^ "National Center for Complementary and Alternative Medicine Consumer Advisory on ephedra". 2004-10-01. Retrieved 2007-02-13. 
  19. ^ "Food and Drug Administration summary of actions regarding sale of ephedra supplements". Retrieved 2007-02-13. 
  20. ^ WebMD page on ephedra supplements. Accessed 7 Feb 2007.
  21. ^ Hiller K, Loew D. 2009. Symphyti radix. In Teedrogen und Phytopharmaka, WichtlM (ed). Wissenschaftliche Verlagsgesellschaft mbH Stuttgart: Stuttgart; 644–646.
  22. ^ Benedek, B., Ziegler, A. and Ottersbach, P. (2010), Absence of mutagenic effects of a particular Symphytum officinale L. liquid extract in the bacterial reverse mutation assay. Phytotherapy Research, 24: 466–468. doi:10.1002/ptr.3000 - http://onlinelibrary.wiley.com/doi/10.1002/ptr.3000/abstract
  23. ^ Mattocks AR 1986. Chemistry and Toxicology of Pyrrolizidine Alkaloids, Academic Press: London; 391.
  24. ^ Cordell, G. A., Quinn-Beattie, M. L. and Farnsworth, N. R. (2001), The potential of alkaloids in drug discovery. Phytotherapy Research, 15: 183–205. doi:10.1002/ptr.890 - http://onlinelibrary.wiley.com/doi/10.1002/ptr.890/abstract
  25. ^ [1] Winston, David. Herbal Medicine Introduction
  26. ^ Tyler, VE; Robbers JE (1999). Tyler's Herbs of Choice: The Therapeutic Use of Phytomedicinals. Routledge. pp. 6–8. ISBN 0789001594. 
  27. ^ Tyler, VE (1999-08-31). "False Tenets of Paraherbalism". Quackwatch. Retrieved 2012-04-28. 
  28. ^ Fabricant DS, Farnsworth NR (March 2001). "The value of plants used in traditional medicine for drug discovery". Environ. Health Perspect. 109 Suppl 1 (Suppl 1): 69–75. PMC 1240543. PMID 11250806. 
  29. ^ Eric Yarnell, N.D., R.H., and Kathy Abascal, J.D (2002). "Dilemmas of Traditional Botanical Research". HerbalGram. 55: 46–54. 
  30. ^ Whole Foods Magazine
  31. ^ "Herbal medicine". Cancer Research UK. Retrieved August 2013.